Get the Stockscreener App
0.00
100.00%
-2.27
After Hours:
2.25
2.25
+
Acelyrin Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
See More
Previous Close:
$2.27
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$227.15M
Revenue:
-
Net Income/Loss:
$-299.80M
P/E Ratio:
0.00
EPS:
-2.84
Net Cash Flow:
$-217.49M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$6.52
Acelyrin Inc Stock (SLRN) Company Profile
Name
Acelyrin Inc
Sector
Industry
Phone
805-456-4393
Address
4149 LIBERTY CANYON RD., AGOURA HILLS
Compare SLRN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLRN
Acelyrin Inc
|
0.00 | 227.15M | 0 | -299.80M | -217.49M | -2.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Acelyrin Inc Stock (SLRN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-08-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-13-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-08-23 | Initiated | Citigroup | Neutral |
| Sep-13-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-05-23 | Initiated | H.C. Wainwright | Buy |
| May-30-23 | Initiated | Jefferies | Buy |
| May-30-23 | Initiated | Morgan Stanley | Overweight |
| May-30-23 | Initiated | Piper Sandler | Overweight |
| May-30-23 | Initiated | TD Cowen | Outperform |
View All
Acelyrin Inc Stock (SLRN) Latest News
Analyzing net buyer seller activity in Acelyrin Inc.Market Rally & Smart Money Movement Tracker - Newser
Short interest data insights for Acelyrin Inc.Take Profit & Long-Term Capital Growth Strategies - Newser
Is Acelyrin Inc. stock ready for a breakoutPortfolio Value Summary & Weekly Stock Breakout Alerts - Newser
Published on: 2025-08-31 00:19:58 - Newser
Is now a turning point for Acelyrin Inc.Exit Point & Pattern Based Trade Signal System - Newser
What’s the recovery path for long term holders of Acelyrin Inc. - Newser
Real time breakdown of Acelyrin Inc. stock performance2025 Momentum Check & Daily Stock Momentum Reports - Newser
How sentiment analysis helps forecast Acelyrin Inc.Quarterly Growth Report & Technical Buy Zone Confirmations - Newser
Published on: 2025-08-30 22:20:03 - Newser
Ranking Acelyrin Inc. among high performing stocks via toolsJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Chart based exit strategy for Acelyrin Inc.July 2025 Update & Accurate Intraday Trading Signals - Newser
What data driven models say about Acelyrin Inc.’s futureWeekly Trading Summary & Community Driven Trade Alerts - Newser
Is Acelyrin Inc. still worth holding after the dipJuly 2025 Update & Fast Gain Swing Alerts - Newser
Visual trend scoring systems applied to Acelyrin Inc.July 2025 PostEarnings & Risk Controlled Stock Pick Alerts - Newser
How institutional ownership impacts Acelyrin Inc. stock2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
Leading vs lagging indicators on Acelyrin Inc. performanceMarket Growth Summary & Stock Portfolio Risk Control - Newser
Signal strength of Acelyrin Inc. stock in tech scannersVolume Spike & Free Daily Entry Point Trade Alerts - Newser
Custom Dashboard Highlights Acelyrin Inc. Price Momentum getLinesFromResByArray error: size == 0 - thegnnews.com
Is Acelyrin Inc. a good ESG investmentShare Buyback & Consistent Profit Alerts - sundaytimes.kr
Evaluating Acelyrin Inc. with trendline analysisWeekly Market Report & AI Powered Buy and Sell Recommendations - Newser
What’s the MACD signal for Acelyrin Inc.2025 Geopolitical Influence & Fast Gain Swing Trade Alerts - sundaytimes.kr
Can Acelyrin Inc. Regain Momentum After Breakdown2025 Major Catalysts & AI Enhanced Execution Alerts - beatles.ru
Acelyrin Inc Stock (SLRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):